The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.
This grant opportunity is specifically designed for organizations that are either currently receiving awards or are applicant organizations under the PAR-21-293 Clinical and Translational Science Award (UM1 Clinical Trial Optional). The grant is exclusive to the primary UM1 Clinical and Translational Science Award (CTSA) program hub organizations, excluding partner or collaborator institutions. Its broad goal is to support clinical and translational science initiatives, fostering advancements in these areas while emphasizing the importance of primary organizations within the CTSA consortium.